National Institutes of Health (US)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
235
Publications
1644
Citations
222466
i10-index
1044
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Cancer immunotherapy: moving beyond current vaccin... | 2004 | 2980 |
T cells expressing CD19 chimeric antigen receptors... | 2014 | 2938 |
Cancer Regression and Autoimmunity in Patients Aft... | 2002 | 2843 |
A Progress Report on the Treatment of 157 Patients... | 1987 | 2742 |
A Randomized Trial of Bevacizumab, an Anti–Vascula... | 2003 | 2704 |
Observations on the Systemic Administration of Aut... | 1985 | 2673 |
Cancer Regression in Patients After Transfer of Ge... | 2006 | 2638 |
Case Report of a Serious Adverse Event Following t... | 2010 | 2564 |
Adoptive cell transfer as personalized immunothera... | 2015 | 2545 |
Use of Tumor-Infiltrating Lymphocytes and Interleu... | 1988 | 2441 |
Steven A. Rosenberg is a researcher with 1644 publications and 222466 citations. They are affiliated with National Institutes of Health. Their research focuses on Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, T-cell and B-cell Immunology and other areas. With an h-index of 235, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Steven A. Rosenberg and 300M+ other papers.
Citations per publication by year